For cholangiocarcinoma, TGF-β1 acts as a promoter of tumorigenesis through Sp1-dependent transcriptional activation of vascular endothelial growth factor(VEGF) or Snail activation[6,7]. Here, VEGFA is linked to cholangiocarcinoma.